Author:
Conrad Karsten,Bartsch Holger,Canzler Ulrich,Pilarsky Christian,Grützmann Robert,Bachmann Michael
Reference15 articles.
1. Conrad K, Roggenbuck D, Bachmann M. (2005) Autoantibodies as indicators of tumor development. In: Conrad K, Bachmann M, Lehmann W, Sack U (Eds). Methods, Possibilities and Perspectives of Pre-symptomatic Tumor Diagnostics. Pabst Science Publishers, Lengerich, pp 55–77.
2. Tan EM. (2001) Autoantibodies as reporters identifying aberrant cellular mechanism in tumorigenesis. J Clin Invest; 108:1411–1415.
3. Jaeger E, Chen YT, Drijfhout JW, Karbach J, Ringhoffer M, Jaeger D, Arand M, Wada H, Noguchi Y, Stockert E, Old LJ, Knuth A. (1998) Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: Definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med; 187:265–270.
4. Conrad K. (2000) Autoantibodies in cancer patients and in persons with a higher risk of cancer development. In: Shoenfeld, Y, Gershwin ME (Eds). Cancer and Autoimmunity. Elsevier, Amsterdam, pp 159–173.
5. Crawford LV, Pim DC, Bulbrook RD. (1982) Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. Int J Cancer; 30:403–408.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献